A detailed history of Torray LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Torray LLC holds 11,823 shares of AXSM stock, worth $1.11 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
11,823
Previous 11,747 0.65%
Holding current value
$1.11 Million
Previous $945,000 12.38%
% of portfolio
0.16%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$78.93 - $95.84 $5,998 - $7,283
76 Added 0.65%
11,823 $1.06 Million
Q2 2024

Aug 06, 2024

BUY
$65.72 - $80.5 $79,455 - $97,324
1,209 Added 11.47%
11,747 $945,000
Q1 2024

May 10, 2024

BUY
$69.39 - $97.64 $289,980 - $408,037
4,179 Added 65.72%
10,538 $840,000
Q1 2024

May 09, 2024

BUY
$69.39 - $97.64 $441,251 - $620,892
6,359 New
6,359 $507,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $4.01B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Torray LLC Portfolio

Follow Torray LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Torray LLC, based on Form 13F filings with the SEC.

News

Stay updated on Torray LLC with notifications on news.